The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(2aS,2a1S,5S,5aR,6S,9aR)-5-hydroxy-2a-isopropyl-N-methyl-2-tosyldecahydro-6,9a-epoxyazepino[3,4,5-cd]indole-8(9H)-carboxamide ID: ALA5285161
Max Phase: Preclinical
Molecular Formula: C23H33N3O5S
Molecular Weight: 463.60
Associated Items:
Names and Identifiers Canonical SMILES: CNC(=O)N1C[C@H]2O[C@]3(C1)CN(S(=O)(=O)c1ccc(C)cc1)[C@]1(C(C)C)CC[C@H](O)[C@H]2[C@H]31
Standard InChI: InChI=1S/C23H33N3O5S/c1-14(2)23-10-9-17(27)19-18-11-25(21(28)24-4)12-22(31-18,20(19)23)13-26(23)32(29,30)16-7-5-15(3)6-8-16/h5-8,14,17-20,27H,9-13H2,1-4H3,(H,24,28)/t17-,18+,19+,20+,22+,23-/m0/s1
Standard InChI Key: ANSHAZSNFPGMAO-DJIRWREJSA-N
Molfile:
RDKit 2D
35 39 0 0 0 0 0 0 0 0999 V2000
-1.5399 1.8455 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
-0.8255 1.4330 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2122 0.8808 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2600 1.8679 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.1833 2.7677 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.4271 3.5559 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
-0.8255 2.2583 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.8255 3.0833 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
-1.5401 2.6709 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.5401 3.4959 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.2548 2.2583 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.2548 1.4330 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.5401 1.0204 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4606 0.8068 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.0439 1.3902 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.7009 0.0176 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3686 0.2132 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.9520 -0.3701 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-2.7770 -0.3701 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.3652 0.3457 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.7384 -1.1670 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3243 -1.7528 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1062 -2.5480 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3129 -2.7590 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0994 -3.5559 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7294 -2.1754 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9415 -1.3807 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5479 0.1269 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.6214 2.5847 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9815 1.8456 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.8065 1.8456 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.6214 1.1114 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2189 1.1312 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.2189 2.5602 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.0439 2.5602 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 1
2 3 1 0
3 4 1 6
5 4 1 0
5 6 1 6
7 5 1 0
2 7 1 0
7 8 1 1
7 9 1 0
9 10 1 6
11 9 1 0
11 12 1 0
12 13 1 0
2 13 1 0
13 14 1 1
14 15 1 0
14 16 1 0
13 17 1 0
17 18 1 0
18 19 2 0
18 20 2 0
18 21 1 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 1 0
24 26 2 0
26 27 1 0
27 21 2 0
28 17 1 0
3 28 1 0
5 29 1 0
29 30 1 0
30 31 1 0
30 32 1 0
3 32 1 0
31 33 2 0
31 34 1 0
34 35 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 463.60Molecular Weight (Monoisotopic): 463.2141AlogP: 1.57#Rotatable Bonds: 3Polar Surface Area: 99.18Molecular Species: NEUTRALHBA: 5HBD: 2#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: 1.06CX LogD: 1.06Aromatic Rings: 1Heavy Atoms: 32QED Weighted: 0.71Np Likeness Score: 0.05
References 1. Hassan H, Chiavaralli J, Hassan A, Bedda L, Krischuns T, Chen KY, Li ASM, Delpal A, Decroly E, Vedadi M, Naffakh N, Agou F, Mallart S, Arafa RK, Arimondo PB.. (2023) Design and synthesis of naturally-inspired SARS-CoV-2 inhibitors., 14 (3): [PMID:36970153 ] [10.1039/d2md00149g ]